Try our Advanced Search for more refined results
Life Sciences - September, 2020
373 articles
- DOJ Charges 345 In Health Fraud Schemes Topping $6B
- DEA Exploiting Doctrine To Keep Pot Illegal, 9th Circ. Hears
- House Dems Lay Into Pharma CEOs, Urge Price Negotiations
- Teva Inks Patent Deal With Collegium Over Painkiller
- UK Court Rules Meril Infringes Heart Valve IP, But Some Claims Are Invalid
- Purdue Pharma Gets OK For Payments, Opioid Suit Shield
- Gov't Contracts Of The Month: Virus, Nukes And Int'l Travel
- 3rd Circ. Wipes Out FTC's $448M AbbVie Win
- Law360's The Term: The Impact Of Amy Coney Barrett
- Alice Dooms DNA Analysis Patents In Biotech Co.'s Suit
- Atlanta Homeowners Say Sterigenics Plant Cut Property Value
- Cannabis Co. Fights Shareholders' Bid To DQ Attys From Suit
- College Coronavirus Q&A: Cal State's General Counsel
- Pot Co. Says TCPA Plaintiff Signed Up For Texts Before Suing
- Boehringer Ingelheim Wins Pradaxa Wrongful Death Suit
- Walgreens Asks 9th Circ. To Decertify Theranos Class
- Immunomedics Hit With Investor Suit To Halt $21B Gilead Deal
- How Amy Coney Barrett Could Upend Abortion Rights
- Key Contractual Protections For Cos. In The PPE Space
- What We Know About How Judicial Bias Can Influence Rulings
- DuPont Dodges ERISA Suit Thanks To 'Confusion'
- Health Care Clashes Dominate 1st Trump-Biden Debate
- Allergan Investors Lose Class Cert. Bid Over 'Serial Litigant'
- Catalyst Loses Fight Against FDA Approval Of Rival's Drug
- Patents Not 'Barrier' To COVID-19 Vaccine Access, Iancu Says
- Sterigenics Atlanta Property Value Suit May Be Premature
- Surgery Robot Maker Accused Of Banning Third-Party Repairs
- 3rd Circ. Vexed By Vagueness In Abbott Artery Device Suit
- Firm-Pharmacy Referral Deal Raises Red Flags In Mass.
- NJ Podiatrist Loses Fight Over Medical Pot Prescriptions
- Will Barrett Deliver Pivotal Vote To Strike Down The ACA?
- J&J, Mallinckrodt Push For Stay Of NY Opioid Fraud Cases
- PureShield Says Allied Bio Coronavirus Disinfectant Infringes
- Calif. Gov. Vetoes Genetic Testing Privacy Bill
- Cooley And Shearman Steer Biotech Orphazyme's $84M IPO
- Full Fed. Circ. Won't Undo Sandoz Loss In Patent Fight
- Coronavirus Regulations: A State-By-State Week In Review
- Merck, Glenmark Blast 'Extremely Small' Zetia Buyers' Class
- Law Firm Social Responsibility Strategies In The New Normal
- Dental Supply Investors Get Class Cert. In Price-Fixing Suit
- Calif. To Manufacture Its Own Generic Drugs Under New Law
- Ga. Justices Revive Claims In Sperm Bank Sham-Donor Suit
- Pomerantz To Lead Endo Investor Suit Over Opioid Crisis
- Hoffmann-La Roche Can't Shake $1.4B Tamiflu FCA Suit
- Stimwave Founder's Credibility Under Fire At Legal Fee Trial
- Global Opioid Deal In Doubt After 6th Circ. Class Ruling
- Energy Giants Agree To Make EEOC Diversity Data Public
- Judge OKs Worker's Suit Under Pa. Medical Marijuana Law
- Walmart Beats Ex-Pharmacist's Bid To Revive Opioid FCA Suit
- What To Expect On Key Civil Procedure Issues From Barrett
- Blank-Check Sponsors Get Creative In Crowded Market
- Teva Fails To Get $110M Drug Contract Suit Tossed
- Fed. Circ. Revives Jury Ax Of Biogen MS Drug Patent
- What Should A GC Do When The Boss Is Mentally Unfit?
- IUD Users Want Teva Defect Suits Sent To Calif. MDL
- NY Man Charged With COVID-19 Price-Gouging To Donate PPE
- How Law Articles And A Viral Clip Got Barrett The Nomination
- What Happens Now That Amy Coney Barrett Is The Nominee
- Judge Amy Coney Barrett: 7th Circ. Decisions To Know
- Among Democrats, A Growing Appetite To Alter High Court
- What A 6-Vote Majority Would Mean For The Supreme Court
- Judge Barrett Worth Nearly $2M, Disclosures Show
- A History Of Supreme Court Confirmations In 3 Charts
- Trump Chooses Amy Coney Barrett For Ginsburg's Seat
- Dem Reps. Eye High Court Term Limits, Temporary Expansion
- Direct Listings Highlight Busy IPO Week Involving 12 Firms
- Dems Call To Investigate DOD's CARES Act Spending
- Principia Investor Sues For Records On $3.7B Sanofi Deal
- ViSalus Pushes For Trial Redo In $925M Robocall Dispute
- NJ's The Place For Eye Damage MDL, Patients Say
- Mass. AG Says Firm Took Kickbacks To Refer Opioid Patients
- Minority Atty Group Honors Genentech For Diversity Efforts
- Care.com Escapes Investors' Background Check Suit
- Merck Urges Justices To Save Historic $2.5B Patent Verdict
- Gov't Contractors Agree To Pay $900K After Race Bias Probes
- Investor Sues $2.6B Allergy Drugmaker Over Nestle Deal
- Medical Science Co. Wants Hiscox To Foot False Ad Defense
- SEC Says Biotech Boss Conned Investors Over COVID-19 Test
- A Likely Tipping Point For Nonlawyer Ownership Of Law Firms
- The Challenges Facing Trump's Drug Pricing Order
- Ohio Medical Pot Co. Demands Action On Expansion Request
- Shareholders Must Cover Successors' Costs In Aspirin Suit
- Pot Retailer Ignored Routine Sexual Harassment, EEOC Says
- Beware DOJ's Statutory Tool For Fighting COVID-19 Fraud
- UK Litigation Roundup: Here's What You Missed In London
- FDA OKs Import Of Some Prescription Drugs From Canada
- 3 Highlights As Trump Makes Flimsy Vow On ACA Protections
- Pot Co. Says NJ Rival Can't Jump Line For Hoboken Spot
- Appeal 'Overlap' Preserves Akebia Kidney Drug Coverage Suit
- Nevada Regulator Seeks 10-Year Ban For Pot Co.
- J&J, Bausch Look To Finally Flush Talc False Ad Suit
- Patients Say Suit Over Faulty Embryo Tank Not Too Verbose
- MLB Union Slams Opposing Counsel's Ethics In Sanctions Bid
- D.C. Circ. Ponders $600M Rebate Switch Against Mallinckrodt
- Bain-Led Group Inks $2.5B Take-Private Deal With Fiber Co.
- DOJ Support Of SEP Injunctions Should Stabilize Licensing
- Bard Strikes $60M Multistate Deal Over Pelvic Mesh Marketing
- A Road Map For Drafting Persuasive Discovery Motions
- Opioid MDL Negotiating Class Struck Down By 6th Circ.
- Veteran Mental Health Bill Sent To Trump, Other Bills Proceed
- DC Circ. Mulls Vape Makers' Challenge To FDA E-Cig Rule
- Trump's COVID-19 Response Based On Science, Officials Say
- Gilead To Pay $97M To Resolve Copay Kickback Claims
- Boehringer Escapes Suit Over Underfilled Inhalers
- Shire Fights Latest Class Rep In ADHD Drug Antitrust Suit
- Drug Distributors Seek Out Of W.Va. Opioid Bellwether
- Former Pharma Exec Settles SEC Insider Trading Claim
- 3 Firms Win Lead Counsel Roles In Insulin Price-Fixing MDL
- AmerisourceBergen Says Chancery Records Ruling Too Broad
- How Congress Can Depoliticize The Supreme Court
- 5 Ways Retailers Can Mitigate Product Liability Litigation Risk
- Supplement Maker Can't Erase Anti-Aging Fraud Suit In NJ
- Weil Conflict Tainted Insys Exec's Conviction, 1st Circ. Told
- The Case For A Nonpolitical Federal Judiciary
- Pharmacies Lose Bid To Revisit Ruling On Their Opioid Duties
- Chubb Must Defend Rite Aid In Opioid Suits, Del. Court Says
- Takeda Subsidiary Seeks $130M For Drug Firm's Spinoff Fraud
- EU Told That COVID-19 Vaccine Makers Shouldn't Be Liable
- California Consumers Lose Bid For Subclass In Lipitor Case
- ITC Will Review Allergan's Win In Botox Trade Secrets Case
- Coronavirus Regulations: A State-By-State Week In Review
- Feds Slam Regeneron's Attempt To Duck Kickback Suit
- Vt. Legislators Approve Recreational Cannabis Sales, Tax
- Trustee Bristles At New $45M Purdue Bid For Ch. 11 Bonuses
- Catalyst Says FDA Is Breaking Law By Approving Rival's Drug
- Trump's Drug Pricing Order Is More Bark Than Bite
- More Ill. Sterilization Cos. Face Residents' Air Pollution Suits
- Key Regulatory Concerns For Cos. Making COVID-19 Products
- The Keys To A Better Privilege Logging Paradigm
- Justice Ginsburg: Who She Was, How She Shaped The Law
- Law360's The Term: The Life And Legacy Of Justice Ginsburg
- Philip Morris Investors Can't Revive Suit Over E-Cig Sales
- Budding Textualist Star Barbara Lagoa Eyed For High Court
- Sens. Call Purdue CEO Bonus An 'Affront' To Opioid Victims
- McConnell Defends Election-Year Plan To Replace Ginsburg
- House Passes Bill Allowing FDA To Seize Counterfeits
- Labor Unions Appeal Akorn's Ch. 11 Plan Confirmation In Del.
- Mass. Pot Co. Says Regulator Sat On Application For Months
- 3 Key Developments As US Coronavirus Deaths Near 200,000
- Home Depot Ducks Roundup Cancer Warning Suit, For Now
- Zetia Buyers Fight Quick Appeal Of Antitrust Class Cert.
- Nerve Repair Co. Didn't Even Read Claims, Investor Says
- Buyers Fight CVS, Walgreens' Bid To Exit Blood Pressure MDL
- Health Experts Detail COVID-19 Vaccine Trial For Navajo
- White House Due Process Memo Could Reform Enforcement
- Cravath, Latham Craft $8B Deal For Cancer Detection Biz
- Birthdays, Weddings And In Between: RBG And Her Clerks
- Our 'North Star': What RBG Means To Women In Law
- Will The Senate Replace Ginsburg Before Election Day?
- 5 To Watch As GOP Races To Fill Ginsburg's Seat
- RBG's Biggest Opinions, From Civil Rights To Civil Procedure
- Roundup Atty Gets 2 Years For $200M Extortion Plot
- House Forwards Bill On Counterfeit Medical Devices
- High Court Told $268M Hearing Aid Patent Award Flouts Law
- Pot Co. Can't Get Rehearing In License Ownership Dispute
- 12 Firms To Guide IPOs Exceeding $2B As September Sizzles
- In Her Own Words: 4 Of Ginsburg's Strongest Bench Dissents
- Cannabis Regs: NJ Clears New Dispensary Amid License Suit
- With The Passing Of Ginsburg, The Left Loses An Icon
- Justice Ginsburg, 87, Dies Of Cancer Complications
- Gilead Accused Of Paying To Stave Off HIV Drug Competition
- Alzheimer's Biotech Leads Trio Of IPOs To Raise $428M Total
- Wholesaler Fights To Stay Suboxone Product-Hop Class Rep
- 3 Things Attys Still Want To See On IRS Cannabis Website
- Lawmakers Say Akin Gump Report Doesn't Clarify Kodak Loan
- Merck Says Vaccine Buyers Must Arbitrate Antitrust Suit
- Law Firm Hiring Considerations In A COVID-19 Economy
- Kaplan Fox Nabs Lead In Investors' Rapid Virus Tests Suit
- How Pharma Cos. Can Evaluate Alliance Agreements' Validity
- Derivative Suit Says Biotech Co. Lied About COVID-19 Vaccine
- 3rd Circ. Backs Allergan's Win In ERISA Suit Over Drug Prices
- Hagens Berman Inks Deal To End Pa. Legal Malpractice Suit
- Federal Court Wipes Hands Of Maryland Pot Licensing Fight
- Feds Resist Merging Kickback Suits Against Teva, Regeneron
- Ixchel Loses 9th Circ. Appeal In Antitrust Row With Biogen
- NY Files Charges Against J&J Over Opioid Marketing
- Ashland Plant Workers Win Approval For $3.9M Wage Deal
- Purdue Wants Opioid Suit Ch. 11 Shield Extended To March
- Bristol Myers, Dr. Reddy's Settle Revlimid Patent Suits
- Feds Want In On Private Price-Fix Suits Versus Teva
- K&L Gates Snaps Up Calif. IP Pro From Knobbe Martens
- Energy, Biotech Companies Float IPOs Totaling $575M
- 5 More Companies Raise $2.4B As IPO Market Keeps Rolling
- Fed. Circ. Constraints On PTAB Expertise Are Problematic
- Pot Co.'s Ex-GC Says He Was Fired Over Age, Whistleblowing
- South Dakota Neurosurgeon Can't Dodge FCA Suit
- GNC Gets Nod For $770M Ch. 11 Sale To Harbin Pharma
- House Dems Delay Vote To Deschedule Marijuana
- Anthem Slips Pharmacy's Suit Over Alleged Network Shutout
- Lawyers Must Act To Preserve Democracy This Election
- Natera Fights Illumina's Bid To Invalidate DNA Testing Patent
- SDNY Judge Says She's 'DONE' With Serenity, Ferring IP Case
- Akin Gump's Probe Of Kodak Loan Finds No Law Violations
- USPTO Defers Fees On COVID-19 Provisional Applications
- Akerman Guides Fla. Pot Giant Trulieve's $66M Entry Into Pa.
- 7 Firms Steer 3 More IPOs Totaling $909M In Red-Hot Market
- W.Va. Ax Of Biogen MS Drug Patent Binds Del. Litigation
- HHS Unveils Vaccine Rollout Details As Dems Seek Oversight
- Real Estate Rumors: ESJ, Opentrons, Cars.com
- Senate IP Chair Floats Patent Transparency Program To Iancu
- Kirkland Alum Among 2 Prosecutors Tapped For Tenn. Bench
- Patients' Groups Drop Suit Over Utah's Medical Pot Law
- Dollar General Hit With False Ad Suit Over Infant Pain Reliever
- How To Effectively Defend Witnesses In Remote Depositions
- Mo. Agency Evasive In Medical Pot Investigation, Report Says
- Stryker Awarded $2.5M Pre-Filing Interest In Insurance Fight
- Rejected Pa. Medical Pot Licensee Has Right To See Score
- 11th Circ. Won't Toss $2M Verdict Against RJ Reynolds
- Pa. Medical Pot Applications Should Be Public, Justices Hear
- Bayer's Roundup Settlements Back On After 'Slight Hiccup'
- Ex-Acclarent Execs Can't Slip Misbranding Convictions
- Bernstein Litowitz, Kessler Topaz Lead Mylan Stock-Drop Suit
- Kirkland Guides Health-Focused SPAC's $500M IPO Plans
- Dana-Farber Tells Fed. Circ. Not To Revisit Inventorship Ruling
- Sidley, Latham Steer Dialysis Co. Outset's Upsized $242M IPO
- DC Circ. Urged To Rethink HHS Cuts To Hospital Payments
- J&J Workers Fight To Keep Asbestos ERISA Suit Alive
- House Dems Urge Justices To Hear Pot Legalization Fight
- Whether And How To Compel Remote Arbitration
- The Hurdles In Defending COVID-19 Contract Nonperformance
- 9th Circ. Doubts Drugmakers' Bid To Revive Free Speech Suit
- Dems Say Trump Appointees Politicized CDC Virus Reports
- Cannabis Attys Press Justices To Hear Pot Legalization Case
- Scripps Research Pays $10M To Settle Federal Grant FCA Suit
- Discovery OK'd In Pfizer Dispute With IRS For Tax Interest
- GNC Nixes Ch. 11 Auction To Go With $770M Harbin Deal
- Trump's Latest Drug Pricing Executive Order Draws Doubts
- PE-Backed GoodRx Leads 4 IPO Launches Totaling $1.4B
- Coronavirus Q&A: Venable's FDA Co-Chair
- Trulieve Says Canadian Listing Bars Securities Suits
- 4 Inventorship Lessons From Fed. Circ.'s Dana-Farber Ruling
- Pot Co. Beats Wrongful Firing Claim In Tax Scheme Suit
- The Unique Challenges Of Protecting A Law Firm Brand
- ITC Says US Methionine Biz Likely Hurting From Imports
- Merck Strikes Total $1.7B Collabs With Cancer Biotech Co.
- 2nd Circ. Reinstates NY Tax On Opioid Distributors
- Pot Biz Can Use Alternate Tax Accounting Method, IRS Says
- Actavis $19M Deal In ADHD Drug Antitrust Suit Gets Initial OK
- Davis Polk, Wachtell Build Gilead's $21B Immunomedics Buy
- Judge Slams Hagens Berman's Pause Bid As Stalling Tactic
- Neb. Medical Pot Backers Say Court Ruling Won't Stop Them
- 15 Firms To Steer IPOs Totaling $6.7B Amid Market Blitz
- Former PetMed Execs Ink $2.5M Deal To End SEC Suit
- 5th Circ. Asked To Revive Claims Drugs Caused Disease
- ADHD Med Buyers Can't Yet Appeal Class Cert. Denial
- Fla. High Court Again Told Medical Pot Law Unconstitutional
- Denali's Directors 'Grossly' Overpaid, Chancery Suit Says
- Insys Boss Tells 1st Circ. Feds Made Him Opioid 'Scapegoat'
- HHS Grilled Over $250M Coronavirus Publicity Campaign
- The Dollars And Sense Of Antitrust Class Certification: Part 2
- UK Litigation Roundup: Here's What You Missed In London
- Judge Rejects Vivus' Ch. 11 Plan, Wants Equity Panel Formed
- Cannabinoid Maker Hits Amyris With $881M Trade Secrets Suit
- Feds Can Test Ex-Theranos CEO's 'Mental Disease' Defense
- State AGs Say Drugmakers Want To Delay Price-Fixing Trials
- Dems Say CMS Chief Spent $6M On 'Personal Brand' Advisers
- Teva Severance Pay Claim Is Sent To State Court
- Neb. Supreme Court Blocks Medical Pot Initiative From Ballot
- Illumina Must Let Inventors Be Deposed In DNA Patent Suit
- Ex-BigLaw Atty Takes 3-Year Suspension For Insider Trading
- Green Thumb Says Botched Appraisal Forced It To Overpay
- FDA Warns Websites Over Illegal Opioid Sales
- Takeda Plasma Co. Hit With Ill. Finger Scan Privacy Claims
- True Health's Ch. 11 Confirmation Affirmed Over Feds' Protest
- Judge Trims Invisalign Maker Shareholder Suit
- 5 Noncompete Developments To Watch For As 2020 Ends
- Takeaways From DOJ Civil Division's Inability-To-Pay Memo
- 3 Developments As Trump Admits Downplaying Virus Threat
- Drugmakers Want Zetia 'Shortcut' Cert. Short-Circuited
- France Fines Pharma Cos. €444M For Abuse Of Dominance
- 3D Software Provider Leads 4 IPO Launches Totaling $1.5B
- House Committee Advances Medical Marijuana Research Bill
- Columbia Care Can't Dodge Fla. Pot Trade Secret Fight
- Doctor Says FDA Made Wrong Call On Opioids In NY AG Suit
- Amneal Gets Del. Judge To Invalidate Estrogen Patch IP
- W.Va. Opioid Trial Prep Under Time Crunch Due To Pandemic
- Ex-Analysts Pitch Insider Trading Challenge To High Court
- Inventor Can't Use Iancu's St. Jude Conflict To Ditch IPR
- Key FDA Drug Inspection Challenges Amid COVID-19
- WilmerHale Builds Life Sciences Presence With Boston Hire
- What To Know When Making Dispositive Motions In Arbitration
- Ex-GC Nets Early Win Against CBD Cos. Over Stocks, Benefits
- Glaxo Loses Appeal For Asthma Inhaler Color Trademark In EU
- Big Pharma CEOs Vow No Shortcuts On COVID-19 Vaccine
- Fed. Circ. OKs Cattle Breeding Patent, Kolcraft's $4.4M Win
- Justices Urged To Weigh Ex-NFL Player's Pot Legalization Bid
- Indivior Wants Class Rep DQ'd In Suboxone Product-Hop Suit
- Senate GOP Unveils 'Targeted' COVID-19 Relief Package
- Democratic AGs Return Fire In High Court Abortion Pill Row
- CBP Must Secure Lapsing Medical Contract, Watchdog Warns
- Insurer Loses 3rd Circ. Coverage Row Over Drug Trial Suit
- Michigan City Beats Medical Marijuana Permit Fight
- Fresenius Accuses Rival Of Infringing Naropin Patent
- FTC Says 3rd Circ. Ruling Can't Help AbbVie In AndroGel Case
- Ohio Counties Blast Pharmacies' Review Bid In Opioid MDL
- Ex-Insys Execs Cite Virus, Family In Bid To Delay Sentences
- Coronavirus Regulations: A State-By-State Week In Review
- 4 Ways Amicus Briefs Can Support An Overall Legal Strategy
- High Court Should Review Horizon Arthritis Drug Patent Case
- 'You Lose,' Fed. Circ. Judge Says In Cattle Breeding IP Fight
- 7th Circ. Told Insurer Has No Duty To Cover $3.3M TCPA Deal
- Express Scripts Defeats Patient Poaching Appeal At 8th Circ.
- Md. Pot Agency Says Probe Finds No Bias In License Process
- HHS Unit Probes Funding For Moderna's Patented Vaccines
- Calif. Judge Rules Cyan Loophole 'Not Illegal' Under State Law
- Fed. Circ. Judge Wary Of St. Jude Heart Valve Patent Defense
- Brand Battles: Johnson & Johnson Rips On 'Handaid' TM
- Ferring Fights To Revive Drug IP Inventorship Dispute
- Taxation With Representation: Debevoise, Wilson, Mayer
- Drug-Device Combos Divide Orange Book Feedback
- Stryker, XL Clash Over Interest After Insurance Verdict
- Buchanan Ingersoll Taps Litigator To Chair 4 Fla. Offices
- Akorn Ch. 11 Plan Confirmed Over MDL Plaintiffs' Objection
- The Enforcement Vacuum Surrounding 340B Drug Pricing
- Teva's $23B Opioid Litigation Deal Faces New Wave Of Attacks
- Cocrystal Pharma's Reforms To End $27M Stock Plot Suits
- 2 FCA Defenses Can Address Vague Pandemic-Related Rules
- Deciding Whether Co-Mediation Is Right For Your Case
- 3 Trends To Watch As Fall IPO Pipeline Gets Ready To Burst
- I-Mab Bags AbbVie Partnership, Nets $418M From Investors
- Supplement Co.'s $925M Loss A Wake-Up Call On Robocalls
- Boehringer Blocked From Making False GSK Inhaler Claims
- Investor Sues To Halt J&J's $6.5B Momenta Buy
- Nats Catcher Drops MLB Drug Suspension Challenge
- Humana's Glumetza Suit Too Little, Too Late, Court Told
- 4th Circ. Halts Trump Admin.'s Abortion Referral Rule
- DOJ Environment Chief To Take Helm At Civil Division
- Fed. Circ. Won't Revive Amarin's Vascepa Patents
- Coronavirus Litigation: The Week In Review
- 5 Steps To Help Universities Manage Foreign Influence Risk
- Activists Expand Effort To Expose Moderna's Vaccine Patents
- Patent License Considerations After Fed. Circ. Enbrel Ruling
- Wearable Medical Device Maker Raises $100M In Financing
- FAQs For 3rd Parties In Gov't Merger Suits Amid Pandemic
- Loeb & Loeb-Guided SPAC Ditches Warrants In $145M IPO
- Black Law Firm Leaders On Improving Diversity In BigLaw
- Ariz. Law Firm Ownership Rule Change Is A Win For Clients
- Emory Asks 11th Circ. To Back Win In Doctor's Race Bias Suit
- AbbVie Can't Escape Investors' Humira Kickbacks Suit
- FDA Remarks On CBD Should Restart Suit, Consumers Say
- Perrigo Fights AbbVie's Bid To Send Pa. Antitrust Suit To NJ
- J&J's South Carolina Appeal Ends After Plaintiffs Drop Cases
- 5th Circ. Rules Ex-Stryker Worker Owes Co. $2.3M In Atty Fees
- $184M Settlements OK'd In Loestrin Buyers' Antitrust Row
- 3 Firms Guide $568M Biopharma Go-Public Deal
- 15 Years Of Ohio Product Law Have Been Good For Cos.
- House To Probe Pandemic Deals Brokered By Trade Adviser
- Wash. AG Sues Juul Over Youth Marketing
- White & Case Guides Life Sciences SPAC To $385M IPO
- How To Write A Better Comment Letter On Agency Proposals
- Israeli Co.'s $20M Float Sinks Amid Life Science IPO Wave
- Iancu Says Congress May Be Up For Patent Eligibility Reform
- AbbVie Faces House Subpoena Over Humira Pricing
- Allergan, Teva Accused Of Hiding 'Critical' Opioid Info
- SEC Pays $2.5M Whistleblower Award To Wall Street Analysts
- Monsanto Asks Calif. High Court To Ax Cancer Liability Loss
- Kite Pharma Wants Fed. Circ. To Nix Juno's $1.2B Patent Win
- FDA Guidance Addresses Wave Of Impurities In Popular Drugs
- CMS Wants Medicare To Cover 'Breakthrough' Devices Faster
- Akorn's Ch. 11 Sale Gets Court Approval In Del.
- ABB Optical Settles Out Of Contact Lens Price-Fix MDL
- Timely Fraud Reporting Rule Under Fire In Whistleblower Suit
- Chinese Medical Equipment Spared From Duties Until 2021
- Teva Hit With Suit In NY Over Broken Birth Control Implant
- Genetic Testing Privacy Bill Clears Calif. Legislature
- Cigna Gets Suits Over Drug Prices Pared Down
- PE Credit Considerations After IntegraMed Ch. 7 Ruling
- Coronavirus Regulations: A State-By-State Week In Review
- J&J Loses Pa. High Court Appeal Bid In $70M Risperdal Case
- The Problem With Collectability In Legal Malpractice Cases
- Dr. Reddy's Inks Deal To Exit Namenda Pay-For-Delay Suit
- Pricey Biogen 401(k) Plan Was 'Glaring Breach,' Suit Says
- Whistleblower Swap Doesn't Kill FCA Standing, 3rd Circ. Says